Molecular Partners AG (MOLN) CHF0.1

Sell:3.28 CHFBuy:3.36 CHFPrice unchangedNo change

Prices delayed by at least 15 minutes
Sell:3.28 CHF
Buy:3.36 CHF
Change:Price unchangedNo change
Deal now
Prices delayed by at least 15 minutes
Sell:3.28 CHF
Buy:3.36 CHF
Change:Price unchangedNo change
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open3.30 CHF
Previous close3.30 CHF
Market capCHF 133.24m
P/E ratio-99999.99
Volume11,913
Dividend yield0.00%
EMS-

Company information

Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that ...

  • LocationSwitzerland
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyCHF
  • Shares in issue40.37m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Balance sheet 2025

Total assetsCHF 102.11m
Total liabilitiesCHF 21.77m
Net debt-CHF 89.41m

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.